These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 20002543

  • 1. RGD-ligand mimetic antagonists of integrin alphaIIbbeta3 paradoxically enhance GPVI-induced human platelet activation.
    Jones ML, Harper MT, Aitken EW, Williams CM, Poole AW.
    J Thromb Haemost; 2010 Mar; 8(3):567-76. PubMed ID: 20002543
    [Abstract] [Full Text] [Related]

  • 2. Glycoprotein IIb/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses.
    Judge HM, Buckland RJ, Holgate CE, Storey RF.
    Platelets; 2005 Nov; 16(7):398-407. PubMed ID: 16236601
    [Abstract] [Full Text] [Related]

  • 3. AlphaIIbbeta3 priming and clustering by orally active and intravenous integrin antagonists.
    Hantgan RR, Stahle MC, Connor JH, Connor RF, Mousa SA.
    J Thromb Haemost; 2007 Mar; 5(3):542-50. PubMed ID: 17166246
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Distinct contributions of glycoprotein VI and alpha(2)beta(1) integrin to the induction of platelet protein tyrosine phosphorylation and aggregation.
    Kamiguti AS, Theakston RD, Watson SP, Bon C, Laing GD, Zuzel M.
    Arch Biochem Biophys; 2000 Feb 15; 374(2):356-62. PubMed ID: 10666318
    [Abstract] [Full Text] [Related]

  • 6. Inhibitory effects of glycoprotein IIb/IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation.
    Nannizzi-Alaimo L, Alves VL, Phillips DR.
    Circulation; 2003 Mar 04; 107(8):1123-8. PubMed ID: 12615789
    [Abstract] [Full Text] [Related]

  • 7. Characterization of a novel function-blocking antibody targeted against the platelet P2Y1 receptor.
    Karim ZA, Vemana HP, Alshbool FZ, Lin OA, Alshehri AM, Javaherizadeh P, Paez Espinosa EV, Khasawneh FT.
    Arterioscler Thromb Vasc Biol; 2015 Mar 04; 35(3):637-44. PubMed ID: 25593131
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Different effects of various anti-GPIIb-IIIa agents on shear-induced platelet activation and expression of procoagulant activity.
    Goto S, Tamura N, Li M, Handa M, Ikeda Y, Handa S, Ruggeri ZM.
    J Thromb Haemost; 2003 Sep 04; 1(9):2022-30. PubMed ID: 12941046
    [Abstract] [Full Text] [Related]

  • 10. Micromolar concentrations of citalopram or escitalopram inhibit glycoprotein VI-mediated and integrin αIIbβ3-mediated signaling in human platelets.
    Tseng YL, Braun A, Chang JP, Chiang ML, Tseng CY, Chen W.
    Toxicol Appl Pharmacol; 2019 Feb 01; 364():106-113. PubMed ID: 30592962
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. P2Y12 receptor blockade augments glycoprotein IIb-IIIa antagonist inhibition of platelet activation, aggregation, and procoagulant activity.
    Berny-Lang MA, Jakubowski JA, Sugidachi A, Barnard MR, Michelson AD, Frelinger AL.
    J Am Heart Assoc; 2013 May 15; 2(3):e000026. PubMed ID: 23676293
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Platelet alpha IIb-beta 3 integrin engagement induces the tyrosine phosphorylation of Cbl and its association with phosphoinositide 3-kinase and Syk.
    Saci A, Rendu F, Bachelot-Loza C.
    Biochem J; 2000 Nov 01; 351 Pt 3(Pt 3):669-76. PubMed ID: 11042121
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Adenosine diphosphate (ADP)-induced thromboxane A(2) generation in human platelets requires coordinated signaling through integrin alpha(IIb)beta(3) and ADP receptors.
    Jin J, Quinton TM, Zhang J, Rittenhouse SE, Kunapuli SP.
    Blood; 2002 Jan 01; 99(1):193-8. PubMed ID: 11756171
    [Abstract] [Full Text] [Related]

  • 19. Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets.
    Schwarz M, Meade G, Stoll P, Ylanne J, Bassler N, Chen YC, Hagemeyer CE, Ahrens I, Moran N, Kenny D, Fitzgerald D, Bode C, Peter K.
    Circ Res; 2006 Jul 07; 99(1):25-33. PubMed ID: 16778135
    [Abstract] [Full Text] [Related]

  • 20. Identification of P2Y12-dependent and -independent mechanisms of glycoprotein VI-mediated Rap1 activation in platelets.
    Larson MK, Chen H, Kahn ML, Taylor AM, Fabre JE, Mortensen RM, Conley PB, Parise LV.
    Blood; 2003 Feb 15; 101(4):1409-15. PubMed ID: 12393417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.